Dr Paul Jourdan of Amati’s UK Listed Smaller Companies Fund offers insight into recent portfolio activity and outlook

Metals are becoming more critical by the day – Tune in to recent update from fund manager Georges Lequime

Join Amati fund managers Mikhail Zverev and Graeme Bencke as they discuss how advances in genomic sequencing are driving a new phase of adoption in healthcare, with important implications for diagnostics companies and investors.